CD1A and allergic disease: Concerning to the mechanisms involved in clinical allergy to urushiols in humans, in addition to the direct presentation of unmodified urushiols on CD1a molecules to human lymphocytes [9], our findings here suggest that there is also the generation of mitochondrial neoantigens, which would stimulate an specific T-cell response independently of CD1a.